FinancialContent is the trusted provider of stock market information to the media industry.
More NewsMore News
* Catalyst Pharmaceuticals announces agreement with FDA on confirmatory phase 3 study protocol for Firdapse in Lambert-Eaton Myasthenic Syndrome Read More
10 Stocks Moving In Monday's Pre-Market Session
June 13, 2016
Gainers Eleven Biotherapeutics Inc (NASDAQ: EBIO) shares rose 85.03 percent to $3.46 in pre-market trading as the company ... Read More
Catalyst Pharmaceuticals Announces Agreement with FDA on Confirmatory Phase 3 Study Protocol for Firdapse in Lambert-Eaton Myasthenic Syndrome
June 13, 2016
Reorganized operations plan projects that current capital resources are adequate to reach NDA acceptance Read More
Technical Analysis on Drugs - Generic Equities -- Akorn, Ironwood Pharma, Catalyst Pharma, and Pacira Pharma
June 10, 2016
from PR Newswire
Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that... Read More
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here